SLXN

AS OF

Dec 12 closing price

Price

$2.81

Change

-$0.23 (-7.57%)

Capitalization

8.79M

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

SLXN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Silexion Therapeutics (SLXN) Ownership - Who owns Silexion Therapeutics?

Silexion Therapeutics Corp a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for KRAS-driven cancers... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Fundamentals

SLXN

Capitalization

8.79M

P/E Ratio

0.01

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

9.24M

Total Cash/Share

2.96

Total Debt

2.03M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

ROE

N/A

Book Value

6.98M

P/B Ratio

1.26

Cash Flow

N/A

Earnings

349.09

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

42K

Current Ratio

3.97

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-9.24M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-125.80

Shares Held By Institutions

17.3K

Shares Outstanding - Current

3.13M

Total Liabilities

4.64M

Total Volume MTD

N/A

Value

Gain YTD

-89.917

View a ticker or compare two or three

Compare

SLXN

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.

View AI-Driven Trading for SLXN

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details